Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G, Karaca Y, Lechien JR, Kindt N, Decaestecker C, Remmelink M, Larsimont D, Andry G, Hassid S, Rodriguez A, Khalife M, Journe F, Saussez S.
Descamps G, et al. Among authors: khalife m.
J Cancer Res Clin Oncol. 2016 Oct;142(10):2185-96. doi: 10.1007/s00432-016-2203-7. Epub 2016 Jul 1.
J Cancer Res Clin Oncol. 2016.
PMID: 27370781
Free PMC article.